Cargando…
HAT therapy for sepsis: A review of the therapeutic rationale and current clinical evaluation status
Vitamin C-based cluster therapy, which involves the combined application of hydrocortisone, vitamin C, and thiamine (HAT), is a recently proposed new treatment option for sepsis on top of conventional treatment. This therapy has a strong theoretical basis, but its clinical efficacy remains inconclus...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658041/ https://www.ncbi.nlm.nih.gov/pubmed/38028642 http://dx.doi.org/10.1016/j.jointm.2023.04.003 |
_version_ | 1785137347693641728 |
---|---|
author | Sun, Yali Yang, Yongfang Ye, Zhuoyi Sun, Tongwen |
author_facet | Sun, Yali Yang, Yongfang Ye, Zhuoyi Sun, Tongwen |
author_sort | Sun, Yali |
collection | PubMed |
description | Vitamin C-based cluster therapy, which involves the combined application of hydrocortisone, vitamin C, and thiamine (HAT), is a recently proposed new treatment option for sepsis on top of conventional treatment. This therapy has a strong theoretical basis, but its clinical efficacy remains inconclusive. This review summarizes the rationale for HAT therapy for sepsis and describes the evaluation of its efficacy in clinical observational studies and randomized controlled trials, with the aim of providing a reference for the future clinical practice application of HAT therapy in sepsis. |
format | Online Article Text |
id | pubmed-10658041 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-106580412023-06-08 HAT therapy for sepsis: A review of the therapeutic rationale and current clinical evaluation status Sun, Yali Yang, Yongfang Ye, Zhuoyi Sun, Tongwen J Intensive Med Review Vitamin C-based cluster therapy, which involves the combined application of hydrocortisone, vitamin C, and thiamine (HAT), is a recently proposed new treatment option for sepsis on top of conventional treatment. This therapy has a strong theoretical basis, but its clinical efficacy remains inconclusive. This review summarizes the rationale for HAT therapy for sepsis and describes the evaluation of its efficacy in clinical observational studies and randomized controlled trials, with the aim of providing a reference for the future clinical practice application of HAT therapy in sepsis. Elsevier 2023-06-08 /pmc/articles/PMC10658041/ /pubmed/38028642 http://dx.doi.org/10.1016/j.jointm.2023.04.003 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Sun, Yali Yang, Yongfang Ye, Zhuoyi Sun, Tongwen HAT therapy for sepsis: A review of the therapeutic rationale and current clinical evaluation status |
title | HAT therapy for sepsis: A review of the therapeutic rationale and current clinical evaluation status |
title_full | HAT therapy for sepsis: A review of the therapeutic rationale and current clinical evaluation status |
title_fullStr | HAT therapy for sepsis: A review of the therapeutic rationale and current clinical evaluation status |
title_full_unstemmed | HAT therapy for sepsis: A review of the therapeutic rationale and current clinical evaluation status |
title_short | HAT therapy for sepsis: A review of the therapeutic rationale and current clinical evaluation status |
title_sort | hat therapy for sepsis: a review of the therapeutic rationale and current clinical evaluation status |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658041/ https://www.ncbi.nlm.nih.gov/pubmed/38028642 http://dx.doi.org/10.1016/j.jointm.2023.04.003 |
work_keys_str_mv | AT sunyali hattherapyforsepsisareviewofthetherapeuticrationaleandcurrentclinicalevaluationstatus AT yangyongfang hattherapyforsepsisareviewofthetherapeuticrationaleandcurrentclinicalevaluationstatus AT yezhuoyi hattherapyforsepsisareviewofthetherapeuticrationaleandcurrentclinicalevaluationstatus AT suntongwen hattherapyforsepsisareviewofthetherapeuticrationaleandcurrentclinicalevaluationstatus |